A Safety & Efficacy Study of BGS649 in Women With Refractory Endometriosis
Status:
Terminated
Trial end date:
2012-03-21
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine efficacy, safety, tolerability and pharmacokinetics
of multiple doses of BGS649 with concurrent daily administration of combined oral
contraception in patients with refractory endometriosis